All filters
Abstracts
Ritonavir concentrations in hair predict virological outcomes in HIV-infected adolescents with virological treatment failure to atazanavir/ritonavir-based second-line treatment
T. Chawana
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
IMARA SA: Piloting a family-based HIV/STI prevention package for South African adolescent girls and young women
K. Merrill
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
Using Narrative Films to Combat HIV-Related Stigma in Western Kenya: A Pilot Study of Adolescents Living with HIV and their Caregivers
B. Mccoy
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
Tenofovir, Lamivudine and Dolutegravir (TLD) among Rural Adolescents in Zimbabwe, a Cautionary Tale.
V. Kouamou
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
Feasibility and Acceptability of a Peer Youth Led Curriculum to Improve HIV Knowledge in Northern Tanzania: Resilience and Intervention Experience from the Perspective of Peer Leaders
K. Hosaka
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
Trends in HIV self-testing among adolescent and youth populations across sub-Saharan Africa
M. Ethridhge
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
Lopinavir Drug Exposures in African Children with HIV using Lopinavir/ritonavir Pellets Dosed per WHO Weight-Bands
S. Chupradit
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
Exposure to two dolutegravir formulations in children in the ODYSSEY trial
H. Waalewijn
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
Abacavir Weight-Band Dosing for Infants in the First 4 Weeks of Life
T. Cressey
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
Assessing parental choice of Lopinavir/ritonavir granules intake to improve child adherence at Baylor-Mwanza, Tanzania.
C. Gesase
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
Caregivers perception on paedriatic Lopinavir/ritonavir formulations for HIV infected children at Baylor clinic, Mwanza-Tanzania.
C. Gesase
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Fumarate (E/C/F/TAF) on Bone Safety Parameters in Children and Adolescents Living with HIV
N. Rakhmanina
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
Effect of dolutegravir on folate and vitamin B12 status among HIV-infected children and adolescents in the ODYSSEY trial
L. Barlow-Mosha
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
Neuropsychiatric manifestations and sleep disturbances in children and adolescents randomised to dolutegravir-based ART vs standard-of-care in the ODYSSEY trial
A. Violari
​​​​​​​Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
Mutations associated with ineffectiveness of HIV-1 protease inhibitors in children in Abidjan, CĂ´te d'Ivoire
J. Dechi
​​​​​​​Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
Early Trends in HIV Drug Resistance Mutations Among Pediatric and Young Adult (0-24 years) Clients in Sub-Saharan Africa
S. Perry
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
HIV Drug Resistance Patterns Among Highly Treatment-Experienced Children, Adolescents and Young Adults in Sub-Saharan Africa
A. Tiam
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
The road to success is paved with dolutegravir: Dolutegravir treatment success among in children and adolescents living with HIV (CALHIV) at the Baylor Tanzania Centres of Excellence.
J. Bacha
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
Successful Scale- Up of Optimal Antiretroviral Regimens and Improvement in Viral Suppression for Children and Adolescents Living with HIV Amidst COVID 19 Pandemic In Kenya
I. Mutisya
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
Challenges in the effective treatment of infant HIV undermine the potential impact of birth testing and neonatal ART: preliminary results from the LIFE trial in Mozambique and Tanzania
A. Mahumane
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
Adolescent and caregiver perspectives on an enhanced adherence counseling intervention for youth with suspected HIV treatment failure in Kenya
M. Gill
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
Adherence to Antiretroviral Therapy among Children Living with HIV in North-Central Nigeria: a Qualitative Evaluation of Barriers and Facilitators among Caregivers
T. Jasper
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
Viral Load Coverage and Suppression Around COVID-19: Eswatini
M. Abadie
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
The Baylor International Pediatric AIDS Initiative (BIPAI) Network’s progress towards the second and third UNAIDS 95-95-95 goals among CALHIV receiving care in pediatric HIV centers in six countries in sub-Saharan Africa.
J. Bacha
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021